Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The classification "Immune system – immunogen, not a pharmacological target" is a specialized label used in pharmacological databases, such as ChEMBL (Target ID: CHEMBL2367078), to identify substances that function as antigens rather than traditional drug targets (Gaulton et al., 2017, Nucleic Acids Res). An immunogen is defined as any molecule, typically a protein or polysaccharide, capable of eliciting an adaptive immune response, including the production of specific antibodies or the activation of T-cells (CDC, 2023, "Glossary of Vaccinology Terms"). Unlike traditional pharmacological targets like receptors, enzymes, or transporters that are modulated by drugs to alter physiological signaling, immunogens are the active components of vaccines designed to induce long-term protective immunity (WHO, 2021, "How do vaccines work?"). This label is typically applied to viral proteins, bacterial toxins, or tumor-associated antigens when they are administered to stimulate the host's immune system to recognize and neutralize specific threats. Consequently, this entry does not represent a single biological entity but serves as a functional category for agents that facilitate active immunization (PubChem, 2024). The interaction between the immunogen and the immune system is the fundamental basis for prophylaxis against infectious diseases and certain types of therapeutic cancer vaccines.
Induction of a specific immune response, involving both humoral (antibody) and cellular (T-cell) components, to provide active immunity and immunological memory against a specific pathogen or antigen.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune system – immunogen, not a pharmacological target.